Experiment 1003536

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODESTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE

Compounds isolated

NEPHROSTERINIC ACIDLICHESTERINIC ACID,(+):USNIC ACIDLICHESTERYLIC ACIDATRANORINCOLLATOLIC ACID,ALPHA:RANGIFORMIC ACIDOLIVETONIDECOLLATOLONSALAZINIC ACIDPROTOLICHESTERINIC ACID,(+):NEPHROSTERINIC ACID,ISO:PROTOCETRARIC ACIDENDOCROCINALECTORONIC ACIDNEPHROSTERYLIC ACIDMICROPHYLLIC ACIDUSNETIC ACIDOLIVETONIDE PARA-METHYL ETHER

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationHIRAYAMA,T: FUJIKAWA,F: KASAHARA,T: OTSUKA,M: NISHIDA,N: MIZUNO,D:. (1980). ANTITUMOR ACTIVITIES OF SOME LICHEN PRODUCTS AND THEIR DEGRADATION PRODUCTS.. 100()
Amount utilized
Compound isolated
DiseaseDOSING DAILY ON DAYS 1-7.
Dose amount1.0 MG
Number1
Qualitative resultINACTIVE
AnimalMOUSE
Per unitANIMAL
Dose expressionDOSE